{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:38:32Z","timestamp":1787510312202,"version":"build-2736575974"},"reference-count":16,"publisher":"Rambam Health Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10382","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T07:23:25Z","timestamp":1575876205000},"page":"e0005","source":"Crossref","is-referenced-by-count":8,"title":["Medicinal Use of Cannabis in Children and Pregnant Women"],"prefix":"10.5041","volume":"11","author":[{"given":"Gideon","family":"Koren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2983","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Duvall SW, Lindly O, Zuckerman K, Msall ME, Weddle M. Ethical implications for providers regarding cannabis use in children with autism spectrum disorders. Pediatrics 2019;143:e20180558.","DOI":"10.1542\/peds.2018-0558"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-0042-117644","article-title":"Pharmacotherapy in psychiatric disorders of children: current evidence and trends","volume":"49","author":"K\u00f6lch M","year":"2016","unstructured":"2. K\u00f6lch M, Plener PL. Pharmacotherapy in psychiatric disorders of children: current evidence and trends. Pharmacopsychiatry 2016;49:219-25.","journal-title":"Pharmacopsychiatry"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Barchel D, Stolar O, De-Haan T, et al. Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities. Front Pharmacol 2019;9:1521. eCollection 2018.","DOI":"10.3389\/fphar.2018.01521"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief report: Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study","volume":"49","author":"Aran","year":"2019","unstructured":"4. Aran A, Cassuto H, Lubotzky A, Wattad N, Hazan E. Brief report: Cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study. J Autism Dev Disord 2019;49:1284-8.","journal-title":"J Autism Dev Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12888-019-2259-4","article-title":"Current state of evidence of cannabis utilization for treatment of autism spectrum disorders","volume":"19","author":"Agarwal","year":"2019","unstructured":"5. Agarwal R, Burke SL, Maddux M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry 2019;19: 328.","journal-title":"BMC Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jama.2017.21896","article-title":"Prevalence of fetal alcohol spectrum disorders in 4 US communities","volume":"319","author":"May","year":"2018","unstructured":"6. May PA, Chambers CD, Kalberg WO, et al. Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA 2018;319:474-82.","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Moore EM, Riley EP. What happens when children with fetal alcohol spectrum disorders become adults? Curr Dev Disord Rep 2015;2:219-27.","DOI":"10.1007\/s40474-015-0053-7"},{"key":"ref7","unstructured":"8. Ozsarfati J, Koren G. Medications used in the treatment of disruptive behavior in children with FASD--a guide. J Popul Ther Clin Pharmacol 2015;22:e59-67."},{"key":"ref8","unstructured":"9. Koren G, Nulman I. Motherisk guide for diagnosis of FASD. 2nd ed. Toronto, Canada: Motherisk Program; 2014."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0891-4222(95)00037-2","article-title":"The Nisonger Child Behavior Rating Form: age and gender effects and norms","volume":"17","author":"Tass\u00e9","year":"1996","unstructured":"10. Tass\u00e9 MJ, Aman MG, Hammer D, Rojahn J. The Nisonger Child Behavior Rating Form: age and gender effects and norms. Res Dev Disabil 1996;17:59-75.","journal-title":"Res Dev Disabil"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Koren G, Cohen R, Sacks O. Use of cannabis in fetal alcohol spectrum disorder. Cannabis Cannabinoid Res (forthcoming, accepted November 6, 2019).","DOI":"10.1089\/can.2019.0056"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctcp.2005.09.006","article-title":"Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'","volume":"12","author":"Westfall","year":"2006","unstructured":"12. Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'. Complement Ther Clin Pract 2006;12:27-33.","journal-title":"Complement Ther Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Koren G, Boskovic R, Hard M, Maltepe C, Navioz Y, Einarson A. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol 2002;186(5 Suppl Understanding):S22831.","DOI":"10.1067\/mob.2002.123054"},{"key":"ref13","unstructured":"14. Cohen R, Koren G. The use of cannabis in hyperemesis gravidarum. A report from Motherisk Israel. 3rd International Colloquium on Hyperemesis Gravidarum. Amsterdam, the Netherlands, October 10, 2019."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.ajog.2015.05.025","article-title":"Marijuana use in pregnancy and lactation: a review of the evidence","volume":"213","author":"TD","year":"2015","unstructured":"15. Metz TD, Stickrath EH. Marijuana use in pregnancy and lactation: a review of the evidence. Am J Obstet Gynecol 2015;213:761-8.","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ppe.12505","article-title":"Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1-11 years: a systematic review","volume":"32","author":"Sharapova","year":"2018","unstructured":"16. Sharapova SR, Phillips E, Sirocco K, Kaminski JW, Leeb RT, Rolle I. Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1-11 years: a systematic review. Paediatr Perinat Epidemiol 2018;32:512-32.","journal-title":"Paediatr Perinat Epidemiol"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/979\/1\/PublishFiles\/992Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:19:38Z","timestamp":1738732778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/44\/articles\/992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10382","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}